Phenotypic overlap in hypertrophic cardiomyopathy: Apical hypertrophy, midventricular obstruction, and apical aneurysm

Journal of Cardiology

Volumn 64, Issue 6, 2014, Pages 463-469

  Minami, Yuichiro ^a   Haruki, Shintaro ^a   Hagiwara, Nobuhisa ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Aneurysm; Hypertrophic cardiomyopathy; Obstruction; Prognosis

Indexed keywords

ADULT; AGED; ANEURYSM; APICAL ANEURYSM; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE FAILURE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LETHALITY; MAJOR CLINICAL STUDY; MALE; MIDVENTRICULAR OBSTRUCTION; NUCLEAR MAGNETIC RESONANCE SCANNER; OBSTRUCTION; OUTCOME ASSESSMENT; PHENOTYPE; PHENOTYPIC OVERLAP; PHENOTYPIC VARIATION; PREVALENCE; PROGNOSIS; SUDDEN CARDIAC DEATH; ECHOCARDIOGRAPHY; ECHOGRAPHY; GENETICS; HEART LEFT VENTRICLE HYPERTROPHY; HEART OUTFLOW TRACT OBSTRUCTION; JAPAN; MIDDLE AGED; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

ANEURYSM; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; JAPAN; MALE; MIDDLE AGED; PHENOTYPE; RETROSPECTIVE STUDIES; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 84926415757     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.03.003     Document Type: Article

References (30)

1. Maron B.J., McKenna W.J., Danielson G.K., Kappenberger L.J., Kuhn H.J., Seidman C.E., Shah P.M., Spencer W.H., Spirito P., Ten Cate F.J., Wigle E.D. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003, 42:1687-1713.
2. Gersh B.J., Maron B.J., Bonow R.O., Dearani J.A., Fifer M.A., Link M.S., Naidu S.S., Nishimura R.A., Ommen S.R., Rakowski H., Seidman C.E., Towbin J.A., Udelson J.E., Yancy C.W. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011, 58:e212-e260.
3. Goto D., Kinugawa S., Hamaguchi S., Sakakibara M., Tsuchihashi-Makaya M., Yokota T., Yamada S., Yokoshiki H., Tsutsui H. Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: report from the registry data in Japan. J Cardiol 2013, 61:65-70. Investigators JCARE-CARD.
4. Jenab Y., Pourjafari M., Darabi F., Boroumand M.A., Zoroufian A., Jalali A. Prevalence and determinants of elevated high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy. J Cardiol 2014, 63:140-144.
5. Kitaoka H., Kubo T., Baba Y., Yamasaki N., Matsumura Y., Furuno T., Doi Y.L. Serum tenascin-C levels as a prognostic biomarker of heart failure events in patients with hypertrophic cardiomyopathy. J Cardiol 2012, 59:209-214.
6. Kubo T., Kitaoka H., Okawa M., Hirota T., Hayato K., Yamasaki N., Matsumura Y., Yabe T., Doi Y.L. Gender-specific differences in the clinical features of hypertrophic cardiomyopathy in a community-based Japanese population: results from Kochi RYOMA study. J Cardiol 2010, 56:314-319.
7. Eriksson M.J., Sonnenberg B., Woo A., Rakowski P., Parker T.G., Wigle E.D., Rakowski H. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2002, 39:638-645.
8. Maron M.S., Finley J.J., Bos J.M., Hauser T.H., Manning W.J., Haas T.S., Lesser J.R., Udelson J.E., Ackerman M.J., Maron B.J. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 2008, 118:1541-1549.
9. Minami Y., Kajimoto K., Terajima Y., Yashiro B., Okayama D., Haruki S., Nakajima T., Kawashiro N., Kawana M., Hagiwara N. Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2011, 57:2346-2355.
10. Bertrand M.E., Tilmant P.Y., Lablanche J.M., Thieuleux F.A. Apical hypertrophic cardiomyopathy: clinical and metabolic studies. Eur Heart J 1983, 4(Suppl. F):127-133.
11. Binder J., Attenhofer Jost C.H., Klarich K.W., Connolly H.M., Tajik A.J., Scott C.G., Julsrud P.R., Ehrsam J.E., Bailey K.R., Ommen S.R. Apical hypertrophic cardiomyopathy: prevalence and correlates of apical outpouching. J Am Soc Echocardiogr 2011, 24:775-781.
12. Chen C.C., Lei M.H., Hsu Y.C., Chung S.L., Sung Y.J. Apical hypertrophic cardiomyopathy: correlations between echocardiographic parameters, angiographic left ventricular morphology, and clinical outcomes. Clin Cardiol 2011, 34:233-238.
13. Kubo T., Kitaoka H., Okawa M., Hirota T., Hoshikawa E., Hayato K., Yamasaki N., Matsumura Y., Yabe T., Nishinaga M., Takata J., Doi Y.L. Clinical profiles of hypertrophic cardiomyopathy with apical phenotype-comparison of pure-apical form and distal-dominant form. Circ J 2009, 73:2330-2336.
14. Yan L., Wang Z., Xu Z., Li Y., Tao Y., Fan C. Two hundred eight patients with apical hypertrophic cardiomyopathy in China: clinical feature, prognosis, and comparison of pure and mixed forms. Clin Cardiol 2012, 35:101-106.
15. Hamada M., Shigematsu Y., Inaba S., Aono J., Ikeda S., Watanabe K., Ogimoto A., Ohtsuka T., Hara Y., Higaki J. Antiarrhythmic drug cibenzoline attenuates left ventricular pressure gradient and improves transmitral Doppler flow pattern in patients with hypertrophic obstructive cardiomyopathy caused by midventricular obstruction. Circ J 2005, 69:940-945.
16. Efthimiadis G.K., Pliakos C., Pagourelias E.D., Parcharidou D.G., Spanos G., Paraskevaidis S., Styliadis I.H., Parcharidis G. Hypertrophic cardiomyopathy with midventricular obstruction and apical aneurysm formation in a single family: case report. Cardiovasc Ultrasound 2009, 7:26.
17. Harada K., Shimizu T., Sugishita Y., Yao A., Suzuki J., Takenaka K., Hirata Y., Nagai R., Takahashi T. Hypertrophic cardiomyopathy with midventricular obstruction and apical aneurysm: a case report. Jpn Circ J 2001, 65:915-919.
18. Lazaros G., Kouvousis N., Kotsanis A., Matsakas E. Apical hypertrophic cardiomyopathy with midventricular obstruction and apical aneurysm. Int J Cardiol 2007, 114:E45-E47.
19. Matsubara K., Nakamura T., Kuribayashi T., Azuma A., Nakagawa M. Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2003, 42:288-295.
20. Sanghvi N.K., Tracy C.M. Sustained ventricular tachycardia in apical hypertrophic cardiomyopathy, midcavitary obstruction, and apical aneurysm. Pacing Clin Electrophysiol 2007, 30:799-803.
21. Tse H.F., Ho H.H. Sudden cardiac death caused by hypertrophic cardiomyopathy associated with midventricular obstruction and apical aneurysm. Heart 2003, 89:178.
22. Watanabe H., Kibira S., Saito T., Shimizu H., Abe T., Nakajima I., Iino K., Miura M. Beneficial effect of dual-chamber pacing for a left mid-ventricular obstruction with apical aneurysm. Circ J 2002, 66:981-984.
23. Zoghbi W.A., Haichin R.N., Quinones M.A. Mid-cavity obstruction in apical hypertrophy: Doppler evidence of diastolic intraventricular gradient with higher apical pressure. Am Heart J 1988, 116:1469-1474.
24. Hamada M., Shigematsu Y., Ohshima K., Suzuki J., Ogimoto A., Ohtsuka T., Hara Y. Diagnostic usefulness of carotid pulse tracing in patients with hypertrophic obstructive cardiomyopathy due to midventricular obstruction: a comparison with idiopathic hypertrophic subaortic stenosis. Chest 2003, 124:1275-1283.
25. Olivotto I., Cecchi F., Casey S.A., Dolara A., Traverse J.H., Maron B.J. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 2001, 104:2517-2524.
26. Shah A., Duncan K., Winson G., Chaudhry F.A., Sherrid M.V. Severe symptoms in mid and apical hypertrophic cardiomyopathy. Echocardiography 2009, 26:922-933.
27. Ishiwata S., Nishiyama S., Nakanishi S., Seki A. Two types of left ventricular wall motion abnormalities with distinct clinical features in patients with hypertrophic cardiomyopathy. Eur Heart J 1993, 14:1629-1639.
28. Wigle E.D., Sasson Z., Henderson M.A., Ruddy T.D., Fulop J., Rakowski H., Williams W.G. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis 1985, 28:1-83.
29. Fighali S., Krajcer Z., Edelman S., Leachman R.D. Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: higher incidence in patients with midventricular obstruction. J Am Coll Cardiol 1987, 9:288-294.
30. Olivotto I., Cecchi F., Poggesi C., Yacoub M.H. Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging. Circ Heart Fail 2012, 5:535-546.